SELLAS Life Sciences (SLS) Return on Capital Employed (QoQ) (2013 - 2026)
SELLAS Life Sciences (SLS) Return on Capital Employed (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,377.00 |
| Dec 31, 2025 | 2,601.00 |
| Sep 30, 2025 | 2,356.00 |
| Jun 30, 2025 | 3,917.00 |
| Mar 31, 2025 | 9,660.00 |
| Dec 31, 2024 | 8,718.00 |
| Sep 30, 2024 | 12,883.00 |
| Jun 30, 2024 | 362,325.00 |
| Mar 31, 2024 | -464,871.00 |
| Dec 31, 2023 | 303,526.00 |
| Sep 30, 2023 | -210,541.00 |
| Jun 30, 2023 | 2,911.00 |
| Mar 31, 2023 | 14,355.00 |
| Dec 31, 2022 | -26,064.00 |
| Sep 30, 2022 | 3,375.00 |
| Jun 30, 2022 | 164.00 |
| Mar 31, 2022 | -20,873.00 |
| Dec 31, 2021 | -4,295.00 |
| Sep 30, 2021 | -974.00 |
| Jun 30, 2021 | 7.00 |